Works matching IS 01676997 AND DT 2007 AND VI 25 AND IP 4

Results: 15

Pro-apoptotic activity of imidazole derivatives mediated by up-regulation of Bax and activation of CAD in Ehrlich Ascites Tumor cells.

Published in:

Investigational New Drugs, 2007, v. 25, n. 4, p. 343, doi. 10.1007/s10637-006-9033-4

By:

Anil Kumar, C.;
Jayarama, Shankar;
Basappa;
Salimath, Bharathi P.;
Rangappa, Kanchugarakoppal S.

Publication type:

Article

Evaluation of ABT-751 against childhood cancer models in vivo.

Published in:

Investigational New Drugs, 2007, v. 25, n. 4, p. 285, doi. 10.1007/s10637-007-9042-y

By:

Christopher Morton;
Edward Favours;
Kimberly Mercer;
Claire Boltz;
Jeri Crumpton;
Chandra Tucker;
Catherine Billups;
Peter Houghton

Publication type:

Article

A phase I trial of BMS-247550 (NSC# 710428) and gemcitabine in patients with advanced solid tumors.

Published in:

Investigational New Drugs, 2007, v. 25, n. 4, p. 335, doi. 10.1007/s10637-007-9035-x

By:

Martee Hensley;
Don Dizon;
Felicia Derosa;
Ennapadam Venkatraman;
Paul Sabbatini;
Dennis Chi;
Jakob Dupont;
A. Colevas;
Carol Aghajanian

Publication type:

Article

A randomised phase II study of OSI-7904L versus 5-fluorouracil (FU)/leucovorin (LV) as first-line treatment in patients with advanced biliary cancers.

Published in:

Investigational New Drugs, 2007, v. 25, n. 4, p. 385, doi. 10.1007/s10637-007-9040-0

By:

T. Ciuleanu;
M. Diculescu;
N. Hoepffner;
J. Trojan;
V. Sailer;
M. Zalupski;
T. Herrmann;
A. Roth;
J. Chick;
K. Brock;
D. Albert;
P. Philip

Publication type:

Article

Phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group (WJTOG) study.

Published in:

Investigational New Drugs, 2007, v. 25, n. 4, p. 377, doi. 10.1007/s10637-007-9039-6

By:

Koji Takeda;
Nobuhide Takifuji;
Shunichi Negoro;
Kiyoyuki Furuse;
Shinichiro Nakamura;
Yoshiki Takada;
Takanobu Hoso;
Shinichi Hayasaka;
Takashi Nakano;
Jun Araki;
Hiroshi Senba;
Fumiyuki Iwami;
Yasufumi Yamaji;
Masahiro Fukuoka;
Harumichi Ikegami

Publication type:

Article

Human mass balance study of the novel anticancer agent ixabepilone using accelerator mass spectrometry.

Published in:

Investigational New Drugs, 2007, v. 25, n. 4, p. 327

By:

R. Garner;
M. Cohen;
S. Galbraith;
G. Duncan;
T. Griffin

Publication type:

Article

Phase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast cancer: unexpected incidence of hypersensitivity reactions.

Published in:

Investigational New Drugs, 2007, v. 25, n. 4, p. 369, doi. 10.1007/s10637-007-9034-y

By:

Nancy Lin;
Leroy Parker;
Steven Come;
Harold Burstein;
Margaret Haldoupis;
Nicole Ryabin;
Rebecca Gelman;
Eric Winer;
Lawrence Shulman

Publication type:

Article

A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas.

Published in:

Investigational New Drugs, 2007, v. 25, n. 4, p. 359, doi. 10.1007/s10637-006-9031-6

By:

Quincy Chu;
Bahram Forouzesh;
Samira Syed;
Monica Mita;
Garry Schwartz;
Joshua Copper;
Janet Curtright;
Eric Rowinsky

Publication type:

Article

A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance.

Published in:

Investigational New Drugs, 2007, v. 25, n. 4, p. 313, doi. 10.1007/s10637-007-9053-8

By:

Gene Bidwell;
Aisha Davis;
Izabela Fokt;
Waldemar Priebe;
Drazen Raucher

Publication type:

Article

A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomes.

Published in:

Investigational New Drugs, 2007, v. 25, n. 4, p. 357, doi. 10.1007/s10637-007-9047-6

By:

Quincy Chu;
Bahram Forouzesh;
Samira Syed;
Monica Mita;
Garry Schwartz;
Joshua Cooper;
Janet Curtright;
Eric Rowinsky

Publication type:

Article

Taurolidine: a novel anti-neoplastic agent induces apoptosis of osteosarcoma cell lines.

Published in:

Investigational New Drugs, 2007, v. 25, n. 4, p. 305, doi. 10.1007/s10637-007-9052-9

By:

Denise Walters;
Roman Muff;
Bettina Langsam;
Philipp Gruber;
Walter Born;
Bruno Fuchs

Publication type:

Article

Antitumor activity of enzastaurin (LY317615.HCl) against human cancer cell lines and freshly explanted tumors investigated in in-vitro soft-agar cloning experiments.

Published in:

Investigational New Drugs, 2007, v. 25, n. 4, p. 397, doi. 10.1007/s10637-007-9051-x

By:

Axel-Rainer Hanauske;
Olaf Oberschmidt;
Hartmut Hanauske-Abel;
Michael Lahn;
Ulrike Eismann

Publication type:

Article

Pharmacological profiling of novel non-COX-inhibiting indole-pyran analogues of etodolac reveals high solid tumour activity of SDX-308 in vitro.

Published in:

Investigational New Drugs, 2007, v. 25, n. 4, p. 297, doi. 10.1007/s10637-007-9049-4

By:

Elin Lindhagen;
Linda Rickardson;
Gary Elliott;
Lorenzo Leoni;
Peter Nygren;
Rolf Larsson;
Anna Åleskog

Publication type:

Article

Simple, mammalian cell-based assay for identification of inhibitors of the Erk MAP kinase pathway.

Published in:

Investigational New Drugs, 2007, v. 25, n. 4, p. 391

By:

Katerina Pejchalova

Publication type:

Article

Erlotinib and vinorelbine in advanced malignant solid tumors: a phase I study.

Published in:

Investigational New Drugs, 2007, v. 25, n. 4, p. 351, doi. 10.1007/s10637-007-9045-8

By:

Angela Davies;
Cheryl Ho;
Paul Hesketh;
Laurel Beckett;
Primo Lara;
Derick Lau;
David Gandara

Publication type:

Article